Abstract:PURPOSE:Estrogen receptor alpha (ER alpha) mediates the growth stimulation of estrogen in breast cancer cells and is a useful predictive factor for response to endocrine therapy. It is reported that ER alpha was induced in ER alpha negative breast cancer cells by both DNA methyltransferase-1 (DNMT1) inhibitor 5-aza-2'-deoxycytidine (AZA) and histone deacetylase (HDAC) inhibitor trichostatin A (TSA). However, whether the breast cancer cells with induced ER alpha restore response to endocrine therapy requires to be further researched. PATIENTS AND METHODS:Reverse transcriptase-polymerase chain reaction (RT-PCR) method was used to explore the change in the mRNA of ER alpha, PR and pS2 in the ER alpha negative breast cancer cells MDA-MB-435 treated with two chemicals (AZA + TSA). Water-soluble tetrazolium salt-8 (WST-8) method was used to study the proliferation rate of the breast cancer cells. Flow cytometer (FCW) was used to analyze the distribution of cell cycle of these breast cancer cells. Some xenograft models in nude mice were used to further study the results we found in vitro. RESULTS:In this study we observed that the mRNA of ER alpha, PR and pS2 in the ER alpha negative breast cancer cells MDA-MB-435 was re-expressed by treatment with AZA + TSA. The proliferation assay analysis showed AZA + TSA suppressed the proliferation of MDA-MB-435 cells, which were further suppressed by addition of 4-OH Tamoxifen (4-OHT). On the contrary, the proliferation of cells treated with 4-OHT alone showed no difference compared with the vehicle control. Cell cycle analysis showed AZA + TSA treated cells showed S phase arrest, which was partially attenuated by addition of estradiol (E2); furthermore, the effect of E2 on stimulation of cell cycle could be reversed by 4-OHT in the treated cells with induced ER alpha. In vivo experiment xenograft volume of MDA-MB-435 cells treated with AZA + TSA was smaller than that of the control (P < 0.01), and the xenograft of AZA + TSA treated cells was further suppressed by ovariectomy (P < 0.01). CONCLUSIONS:Our data indicate that DNMT1 inhibitor AZA and HDAC inhibitor TSA play important roles in restoring sensitivity of the ER alpha negative breast cancer cells to endocrine therapy in vitro and in vivo.

Transcription Regulation of Gene Expression of Human Sex Hormone Receptors in Breast Cancer Cells Induced by 5-Aza-dc and Trichostatin A

ER alpha negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor.

ERα negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor

The Synergistic Inhibitory Effect of 5-Aza-2-deoxycytidine and Tamoxifen on Estrogen Receptor Alpha Negative Breast Cancer Cell Lines in Vitro

[Expression of ER Alpha in Chemically Induced MDA-MB-435 Cells and Its Responsiveness to Endocrine].

Epigenetic Regulation in Combination with Endocrine Therapy Reducing the Proliferation of NCI-H1975 Cells

The Study on Chemical Suppression of Proliferation of MDA-MB-435 Through AZA and TSA

Expression changes of SRC-1 in breast cancer cells and its relationship with endocirine therapy

[Expression of ER Alpha and SMRT in Apoptosis of Breast Cancer Cells Induced by Tamoxifen].

Trichostatin A Combined with All-trans Retinoic Acid Induce Apoptosis in Human Ovarian Cancer Cell Line SKOV-3

Synergistic effect of trichostatina A combined with all-trans retinoic acid on induction of apoptosis of cervical cancer SiHa cells

A Novel Combinatorial Epigenetic Therapy Using Resveratrol and Pterostilbene for Restoring Estrogen Receptor-α (ERα) Expression in ERα-Negative Breast Cancer Cells

Regulatory mechanisms of steroid hormone receptors on gene transcription through chromatin interaction and enhancer reprogramming

Antiproliferative effects of anastrozole on MCF-7 human breast cancer cells in vitro are significantly enhanced by combined treatment with testosterone undecanoate.

Sensitization To Tamoxifen By Tanshinone Iia In Tamoxifen-Resistant Breast Cancer Cells In Vitro

Effects of Triiodothyronine on Estrogen Receptor-Α and Thyroid Hormone Receptor-Β in Breast Cancer Cells

Transcriptional Upregulation of Breast Cancer Resistance Protein by 17β-Estradiol in ERα-Positive MCF-7 Breast Cancer Cells

Effects of Epigenetic Drugs on BRCA1 and CHD5 Expressions in Breast Cancer Cells

A Study on the Expression of Estrogen Receptor and the Effect of Tamoxifen Treatment in Bladder Cancer

STUDY ON THE EFFECT ALL-TRANS RETINOIC ACID ON PROLIFERATION OF BREAST CANCER MDA-MB-231 CELLS AND UNDERLYING MECHANISM

Transcriptional upregulation of breast cancer resistance protein by 17beta-estradiol in ERalpha-positive MCF-7 breast cancer cells.